ViperWire Advance Peripheral Guide Wire, Sterilized with Ethylene Oxide, Rx Only. Part number 720...

FDA Device Recall #Z-2051-2016 — Class II — June 13, 2016

Recall Summary

Recall Number Z-2051-2016
Classification Class II — Moderate risk
Date Initiated June 13, 2016
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Cardiovascular Systems Inc
Location Saint Paul, MN
Product Type Devices
Quantity 190 units (38 - 5 pack shelf cartons)

Product Description

ViperWire Advance Peripheral Guide Wire, Sterilized with Ethylene Oxide, Rx Only. Part number 72023-02, Model Number VPR-GW-17. Five (5) guide wire pouches in one (1) guide wire box. For use with CSI Peripheral Orbital Atherectomy Devices (OAD), including Stealth 360 and Diamondback 360. Cardiovascular.

Reason for Recall

The pouch label was missing the use by date (UBD) of 2018-04.

Distribution Pattern

US Nationwide distribution.

Lot / Code Information

Lot #160877, UDI Number: (01)10852528005084(17)180430(10)160877.

Other Recalls from Cardiovascular Systems Inc

Recall # Classification Product Date
Z-0394-2022 Class I WIRION EMBOLIC PROTECTION SYSTEM, Delivery Cath... Nov 22, 2021
Z-2385-2021 Class II DIAMONDBACK 360 GEN2 PERIPHERAL ORBITAL ATHEREC... Jul 21, 2021
Z-2386-2021 Class II STEALTH 360 GEN2 PERIPHERAL ORBITAL ATHERECTOMY... Jul 21, 2021
Z-3021-2018 Class II CSI, Orbital Atherectomy System (OAS) Saline In... Apr 13, 2018
Z-0506-2018 Class II Peripheral Diamondback 1.50 Solid OAD, a percut... Sep 14, 2017

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.